Pub. Date : 2008
PMID : 18204257
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Both an anti-vascular endothelial growth factor monoclonal antibody, bevacizumab, and an anti- epidermal growth factor receptor monoclonal antibody, cetuximab, should prolong the survival of advanced or metastatic colorectal cancer by 2-3 months in combination with FOLFIRI or FOLFOX. | FOLFIRI regimen | epidermal growth factor receptor | Homo sapiens |